ReviewInternational journal of molecular sciences2021

Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond.

Thomas Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.